SARAH SEVERO: Open Payments
NPI 1427779990 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,517 in 15 payments from 7 companies in 2025. Trend: 2023 $167 · 2024 $238 · 2025 $1,517
Food & beverage: $1,517
| Company | Payments | Amount |
|---|---|---|
| Lumenis BE inc | 1 | $1,007 |
| ABBVIE INC. | 5 | $221 |
| AstraZeneca Pharmaceuticals LP | 3 | $169 |
| Amgen Inc. | 3 | $52 |
| Eisai Inc. | 1 | $28 |
| Novo Nordisk Inc | 1 | $24 |
| PFIZER INC. | 1 | $16 |
Products named: M22, FARXIGA, QULIPTA, UBRELVY, VRAYLAR, OTEZLA, Leqembi, BREZTRI.
Industry payments across FL — which companies pay providers there.
